Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on Illumina’s powerful sequencers, new, disruptive omics solutions surpass industry standards for…